Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Expansion in Asia-Pacific with second subsidiary, following Australia, pivotal to enrolling patients in phase II trial ...
Just 3 disease-modifying treatments—edaravone, riluzole, and sodium phenylbutyrate and taurursodiol (PB/TURSO)—are currently FDA approved to slow progression of amyotrophic lateral sclerosis (ALS). A ...
COVERING YOUR COMMUNITY. PEOPLE IN BOYNTON BEACH CAME TOGETHER YESTERDAY TO CELEBRATE A GOOD CAUSE. OUR MORNING ANCHOR TRAFFIC ANCHOR YASMINE JULMISSE EMCEED THE 2024 WALK TO DEFEAT ALS, CELEBRATING ...
McCormick played a key role passing Gov. Bill Haslam's Tennessee Promise bill, which offers two-year degrees tuition-free to every Tennessee student.
The actor has a very personal project coming in 2026 with help from Maria Shriver.